The QUEST initiative: QUality of life Evaluation STudy:Assessing Health Related Quality of Life in patients receiving medicinal cannabis.
- Conditions
- Chronic DiseaseChronic PainNeurological DisordersNeurological - Other neurological disordersMental Health - Other mental health disorders
- Registration Number
- ACTRN12621000063819
- Lead Sponsor
- ittle Green Pharma Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 2804
All of the following must be satisfied for enrolment in the study:
•adult patients (aged 18 years and over)
•patient has been identified as eligible to receive medicinal cannabis under the special access scheme (or equivalent in other countries and jurisdictions) by a doctor at participating centres registered to prescribe medicinal cannabis
•patient is able to read and understand English
•patient is able to provide informed consent
•patient has not started medicinal cannabis therapy, or the patient started medicinal cannabis therapy within the previous 2 days (we expect no therapeutic benefit within 2 days)
•patient has not received prescribed medicinal cannabis therapy in the previous 4 weeks (excluding previous 2 days)
•patient has a life-expectancy >3 months
Patients will be excluded from the study if any of the following criteria apply:
•are unconscious or confused
•have cognitive impairment
•are pregnant
•are unable to speak, read and/or write in English
•are denied access to medicinal cannabis under the relevant Special Access Scheme for their country of registration
•are unable to provide informed consent
•are already receiving medicinal cannabis treatment for more than 2 days
•have received prescription medicinal cannabis within the last 4 weeks (excluding previous 2 days)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method